Inhibrx Biosciences Inc.

NASDAQ: INBX · Real-Time Price · USD
23.44
-0.50 (-2.09%)
At close: Aug 15, 2025, 3:59 PM
23.33
-0.47%
After-hours: Aug 15, 2025, 04:34 PM EDT

Inhibrx Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-134.26M 1.72B 1.69B 1.64B 1.6B -271.15M -241.36M -188.67M -172.21M -162.89M -145.23M -125.5M -110.75M -93.73M -81.77M -78.23M -78.14M -75.32M
Depreciation & Amortization
2.79M 2.6M 2.29M 1.89M 1.44M 1.26M 1.19M 1.2M 1.2M 1.21M 1.23M 1.23M 1.22M 1.21M 1.2M 1.15M 1.1M 1.05M
Stock-Based Compensation
11.17M 55.92M 59.87M 63.32M 66.88M 25.61M 23.9M 22.83M 20.99M 20.03M 20.45M 19.28M 18.08M 16.73M 15.05M 12.24M 10.05M 7.36M
Other Working Capital
15.44M 33.51M 33.79M 57.27M 47.6M 29.5M 24.89M 1.96M 1.06M 582K 694K -3M -2.5M -2.8M -1.67M -2.47M -2.23M -4.35M
Other Non-Cash Items
19.81M -1.94B -1.94B -1.94B -1.96B 11.31M 11.23M 6.64M 6.4M 5.8M 5.08M 4.19M 3.53M 3.07M 2.73M 2.44M 6.23M 10.25M
Deferred Income Tax
n/a n/a n/a -4.56M -4.56M -4.56M -4.56M 1K n/a n/a n/a n/a n/a -9K -9K -9K 502K -2.18M
Change in Working Capital
-39.36M -3.87M 4K 28.36M 60.07M 21.13M 15.35M -10.03M -1M 6.58M 3.16M -6.53M -2.23M -12.89M -17.52M -10.68M -13.04M -3.39M
Operating Cash Flow
-139.85M -167.25M -194.41M -207.51M -231.47M -216.41M -193.31M -167.09M -143.68M -128.3M -115.3M -107.32M -90.16M -85.62M -80.32M -73.09M -73.3M -62.23M
Capital Expenditures
-284K -1.5M -2.6M -6.02M -6.59M -5.69M -4.59M -1.42M -587K -592K -686K -686K -875K -967K -864K -1.21M -1.34M -1.29M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 55K 55K 55K 55K n/a
Investing Cash Flow
-284K -1.5M -2.6M -6.02M -6.59M -5.69M -4.59M -1.42M -587K -592K -686K -686K -875K -912K -809K -1.15M -1.28M -1.29M
Debt Repayment
99.97M 99.97M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
35.53M 35.53M 35.66M 3.56M 200.75M 201.6M 201.96M 359.76M 160.38M 219.68M 258.55M 141.38M 141.69M 122M 83.77M 59.28M 194.68M 171.08M
Financial Cash Flow
102.55M 135.5M 74.38M 75.24M 272.43M 240.33M 201.96M 359.76M 160.38M 219.68M 258.55M 141.38M 141.69M 122M 83.77M 59.28M 194.68M 171.08M
Net Cash Flow
-40.29M -35.96M -125.33M -141M 34.37M 18.23M 4.06M 191.25M 16.11M 90.79M 142.56M 33.37M 50.66M 35.48M 2.64M -14.96M 120.1M 107.56M
Free Cash Flow
-140.13M -168.75M -197.01M -213.53M -238.06M -222.1M -197.9M -168.51M -144.27M -128.9M -115.99M -108.01M -91.03M -86.58M -81.19M -74.3M -74.64M -63.52M